COVID-19 update for cross border e-commerce by Alibaba Group focusing on health products

Source: Australian Trade and Investment Commission – Austrade

About event:
COVID-19 is affecting many e-commerce businesses and how consumers shop online. In this difficult time, many brick-and-mortar retailers are watching foot traffic and sales drop to near zero. The most significant shift in consumer behaviour is happening in e-commerce globally. In China, e-commerce platforms are reporting behavioural and demographic shifts. During Spring Festival, daily usage of e-commerce platforms grew 56% week-on-week. Two weeks later it was up a further 96%.
Austrade is working with a number of partners to share market insights on how COVID-19 has impacted cross border e-commerce in different aspects.
In this session, we invited Kevin Li, Business Development Director, from Alibaba Group and James Sung, Business Development Manager for health products to share:
Performance of health products in Tmall, Taobao and Kaola during COVID-19 in China
Performance of health products in Lazada during COVID-19 in ASEAN markets
How can health product merchants engage with online marketplaces in China and ASEAN
What are some of the regulatory requirements for health products on selling online in China and ASEAN